Contributor Page
Mintz
 
Email  |  Website  |  Articles
Contact Details
Tel: +1 617 5426000
Fax: +1 617 5422241
One Financial Center
Boston
MA 02111
United States
By David Barmak
The Department of Labor (DOL) has issued a Notice of Proposed Rulemaking (NPRM) that it estimates would convert more than one million now overtime-exempt workers to non-exempt, overtime-eligible employees.
By Aaron L. Josephson
In our first two Device Modernization series posts, we discussed FDA's 510(k) modernization efforts and the proposed De Novo regulation. FDA has also had a heavy hand in legislative efforts
By Kristen A. Marotta, Sarah Beth S. Kuyers
Regular readers of the blog won't be surprised to hear that there has been another data breach, this time involving a business associate in charge of storing medical records on behalf of health care
By Cynthia Larose, Elana Safner
The Federal Trade Commission ("FTC") has handed down its largest civil penalty ever for violations of the Children's Online Privacy Protection Act ("COPPA").
By Susan Neuberger Weller, Andrew D. Skale, Harold S. Laidlaw
The U.S. Supreme Court held today that bringing a suit for copyright infringement requires that the infringed work actually be registered with the U.S. Copyright Office ...
By Todd Rosenbaum
For an arbitration agreement to be enforceable, the parties must have a reasonable opportunity to understand its terms. See Fagerstrom v. Amazon.com, Inc., 141 F. Supp. 3d 1070 (S.D. Cal. 2015).
By Andrew DeVoogd, Daniel Weinger, Matthew Galica, Christopher Duerden
A recent order from the Northern District of California in AU Optronics Corporation America v. Vista Peak Ventures, LLC, 4:18-cv-04638 (CAND 2019-02-19) ("AU Optronics") ...
By Ellyn Sternfield
Long time readers of our blog may recall that five years ago, I predicted that 2014 might be a game-changing year for the 340B Drug Discount Program.
By Aaron L. Josephson
In our first Device Modernization series post, we discussed how FDA is proposing to modernize the 510(k) review program.
By Eli Greenspan
On Tuesday, executives from seven of the largest pharmaceutical companies testified before the Senate Finance Committee on rising prescription drug prices.
By Cynthia Larose
This month, Mintz's TCPA Digest reviews the Federal Communications Commission's (FCC) adoption of a proposal to extend the Truth in Caller ID rules to calls originating outside the United States ...
By Aaron L. Josephson
On March 5, 2019, FDA Commissioner Scott Gottlieb announced his resignation. The physician and venture capitalist, ​for whom this was ​a second stint at the FDA, intends to leave the agency in about a month to spend more time with his family.
By Michael Renaud, James Wodarski, Marguerite McConihe, Courtney Herndon
There is a common misconception the domestic industry economic prong requirement is insurmountable and an unknowable factor in a patent infringement action at the International Trade Commission, ...
By Cynthia Larose, Natalie A. Prescott
Last week, California State Senator Jackson and state Attorney General Becerra introduced a new bill, Senate Bill 561.
By Eli Greenspan
This week, Congressional oversight of prescription drug prices will continue with two hearings in the Senate Special Committee on Aging, which is led by Sen. Susan Collins (R-ME) and Bob Casey (D-PA).
Contributor's Topics
More...